Samarth Kulkarni is Chief Executive Officer of CRISPR Therapeutics AG. Currently has a direct ownership of 195,085 shares of CRSP, which is worth approximately $10.7 Million. The most recent transaction as insider was on Apr 24, 2017, when has been sold 3,500 shares (Common Shares) at a price of $1.81 per share, resulting in proceeds of $6,335. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 195K
0% 3M change
6.26% 12M change
Total Value Held $10.7 Million

Samarth Kulkarni Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 24 2017
BUY
Exercise of conversion of derivative security
$6,335 $1.81 p/Share
3,500 Added 2.48%
137,547 Common Shares
Apr 21 2017
SELL
Open market or private sale
$51,030 $17.01 p/Share
3,000 Reduced 2.19%
134,047 Common Shares
Apr 21 2017
BUY
Exercise of conversion of derivative security
$5,430 $1.81 p/Share
3,000 Added 2.14%
137,047 Common Shares
Apr 20 2017
SELL
Open market or private sale
$48,608 $17.36 p/Share
2,800 Reduced 2.05%
134,047 Common Shares
Apr 20 2017
BUY
Exercise of conversion of derivative security
$5,068 $1.81 p/Share
2,800 Added 2.01%
136,847 Common Shares
Apr 19 2017
SELL
Open market or private sale
$130,934 $18.04 p/Share
7,258 Reduced 5.14%
134,047 Common Shares
Apr 19 2017
BUY
Exercise of conversion of derivative security
$13,137 $1.81 p/Share
7,258 Added 4.89%
141,305 Common Shares

Also insider at

BDTX
Black Diamond Therapeutics, Inc. Healthcare
RPTX
Repare Therapeutics Inc. Healthcare
CNTA
Centessa Pharmaceuticals plc Healthcare
ABIO
ARCA biopharma, Inc. Healthcare
SK

Samarth Kulkarni

Chief Executive Officer
Boston, MA

Track Institutional and Insider Activities on CRSP

Follow CRISPR Therapeutics AG and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRSP shares.

Notify only if
Any

Insider Trading

Get notified when an Crispr Therapeutics Ag insider buys or sells CRSP shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to CRISPR Therapeutics AG

Track Activities on CRSP